Dyne Therapeutics Inc
NASDAQ:DYN
Income Statement
Earnings Waterfall
Dyne Therapeutics Inc
Revenue
|
0
USD
|
Operating Expenses
|
-265.9m
USD
|
Operating Income
|
-265.9m
USD
|
Other Expenses
|
8.5m
USD
|
Net Income
|
-257.4m
USD
|
Income Statement
Dyne Therapeutics Inc
Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | |||||||||||||
Operating Expenses |
(97)
|
(127)
|
(150)
|
(161)
|
(183)
|
(183)
|
(171)
|
(181)
|
(195)
|
(215)
|
(242)
|
(266)
|
|
Selling, General & Administrative |
(23)
|
(26)
|
(29)
|
(30)
|
(30)
|
(31)
|
(28)
|
(29)
|
(30)
|
(30)
|
(31)
|
(48)
|
|
Research & Development |
(74)
|
(101)
|
(121)
|
(131)
|
(154)
|
(152)
|
(143)
|
(152)
|
(165)
|
(185)
|
(211)
|
(218)
|
|
Operating Income |
(97)
N/A
|
(127)
-30%
|
(150)
-18%
|
(161)
-7%
|
(183)
-14%
|
(183)
+0%
|
(171)
+6%
|
(181)
-6%
|
(195)
-8%
|
(215)
-10%
|
(242)
-13%
|
(266)
-10%
|
|
Pre-Tax Income | |||||||||||||
Interest Income Expense |
0
|
1
|
1
|
1
|
1
|
2
|
3
|
4
|
6
|
7
|
8
|
9
|
|
Total Other Income |
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
Pre-Tax Income |
(98)
N/A
|
(126)
-29%
|
(149)
-18%
|
(160)
-7%
|
(182)
-14%
|
(181)
+1%
|
(168)
+7%
|
(177)
-5%
|
(189)
-7%
|
(208)
-10%
|
(236)
-13%
|
(257)
-9%
|
|
Net Income | |||||||||||||
Income from Continuing Operations |
(98)
|
(126)
|
(149)
|
(160)
|
(182)
|
(181)
|
(168)
|
(177)
|
(189)
|
(208)
|
(236)
|
(257)
|
|
Net Income (Common) |
(98)
N/A
|
(126)
-29%
|
(149)
-18%
|
(160)
-7%
|
(182)
-14%
|
(181)
+1%
|
(168)
+7%
|
(177)
-5%
|
(189)
-7%
|
(208)
-10%
|
(236)
-13%
|
(257)
-9%
|
|
EPS (Diluted) |
-1.9
N/A
|
-2.45
-29%
|
-2.93
-20%
|
-3.1
-6%
|
-3.53
-14%
|
-3.5
+1%
|
-3.23
+8%
|
-3.13
+3%
|
-3.16
-1%
|
-3.4
-8%
|
-3.95
-16%
|
-3.17
+20%
|